different frequency of epidermal growth factor rs76189946 polymorphism genotype in iranian colorectal cancer patients
نویسندگان
چکیده
aim : this study aimed to determinant association between rs76189946 polymorphism of egf gene and risk of colorectal cancer in an iranian population. background : colorectal cancer (crc) is the third most prevalent cancer in both genders worldwide. the determination of genetic variation becomes a new way to etiology of colorectal cancer. epidermal growth factor (egf) is a mitogen that plays an important role in cell growth and tumourigenesis, this protein acts by binding its receptor, egfr. patients and methods : dna samples taken from totally 125 crc patients and healthy controls were amplified by polymerase chain reaction (pcr) for the rs76189946 polymorphism. genotypes were analyzed using restriction fragment length polymorphism (rflp). finally to confirm the rflp procedure, 20 of the pcr products were sequenced using the abi prism 3130xl genetic analyzer and chain termination method (applied biosystems, carlsbad, ca). results : genotype distribution and allele frequency was similar in crc patients and controls individuals. we expect observe c and g allele in both groups but only was found c allele. conclusion : in this study for first time we identified genetic distribution of exonic rs76189946 polymorphism in egf gene both crc patients and healthy controls. these results suggest there wasn’t association between egf polymorphism rs76189946 and risk of colorectal cancer in an iranian population.
منابع مشابه
Different frequency of epidermal growth factor rs76189946 polymorphism genotype in an Iranian colorectal cancer
AIM This study aimed to determinant association between rs76189946 polymorphism of EGF gene and risk of colorectal cancer in an Iranian population. BACKGROUND Colorectal cancer (CRC) is the third most prevalent cancer in both genders worldwide. The determination of genetic variation becomes a new way to etiology of colorectal cancer. Epidermal growth factor (EGF) is a mitogen that plays an im...
متن کاملEpidermal Growth Factor Receptor Mutations in Colorectal Cancer Patients
PURPOSE The epidermal growth factor receptor (EGFR) plays an important role in tumorigenesis and tumor progression of colorectal cancer and leads to the activation of intracellular signaling pathways. The use of anti-EGFR-targeted therapy has increased for patients with colorectal cancer, but patients with EGFR mutations will be resistant to anti-EGFR-targeted therapy. The identification of gen...
متن کاملEpidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
PURPOSE It has been shown that the R497K polymorphism of the epidermal growth factor receptor (EGFR) has attenuated functions in ligand binding, tyrosine kinase activation, and growth stimulation. Because the activation of EGFR results in an unfavorable prognosis of patients with colorectal carcinoma, a pilot study was conducted to assess the influence of this polymorphism on colorectal carcino...
متن کاملEpidermal growth factor receptor-targeted therapy in colorectal cancer.
The epidermal growth factor receptor (EGFR) family plays an important role in colorectal cancer (CRC). EGFR participates in the key process of tumorigenesis and invasion, and its expression correlates with the prognosis of CRC. EGFR-targeted therapy has been widely utilized in stage III and IV CRC. The EGFR antibodies, cetuximab and panitumumab, are widely used in treatment of CRC. There are cl...
متن کاملhuman epidermal growth factor receptor expression in colorectal cancer and its relationship with clinicopathological characteristics
background: some recent studies reported human epidermal growth factor receptor (her-2/neu) as a marker that can be used in immunological studies of colorectal carcinoma for predicting the prognosis and the treatment. therefore, we aimed to investigate the frequency of her-2 expression in patients with colorectal cancer, and explore the relationship between clinicopathological prognostic factor...
متن کاملBiomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.
Genomics and proteomics have held out the promise of individualized medicine for the last 10 or 20 years, but clinical medicine has not yet delivered on this promise. Some cancers, such as breast cancer and some hematologic malignancies, have been at the forefront of individualized therapeutic approaches by integrating molecular biomarkers into treatment decision algorithms. Until recently, the...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
gastroenterology and hepatology from bed to benchجلد ۶، شماره ۱۰، صفحات ۲۰۱۳-۶
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023